OnKure Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
40.5M
on 2026-08-03, from 3.34M on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-10 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
$100.0M
Agreement of 2025-11-06. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-04 is not read yet.
Cash
14.7 quarters
$176.4M on 2026-06-30 ÷ $12.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-03-27 | Private placement incl. 9.43M pre-funded | 18,861,918 | $4.15 | not stated | 8-K ↗ |